Radiotherapy Market Report 2026

Radiotherapy Market Overview

• Radiotherapy market size has reached to $7.89 billion in 2025 • Expected to grow to $10.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Impact Of Rising Cancer Prevalence On Treatment Advancements • Market Trend: Advancements In Image-Guided Radiotherapy (IGRT) Technologies Elevate Precision Tumor Targeting And Treatment Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Radiotherapy Market?

Radiotherapy refers to a medical treatment that uses high doses of radiation to destroy cancer cells and shrink tumors. It is used for managing various types of cancers, either as a standalone therapy or in combination with surgery and chemotherapy. The main therapy types of radiotherapy include external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy involves using high-energy radiation from an external machine to target and destroy cancer cells. It is utilized for various conditions, including prostate, breast, lung, head and neck, colorectal, gynecological, cervical, and penile cancers, and others, and is used by several end users, such as hospitals and diagnostic labs, cancer treatment and research centers, academic institutions, ambulatory surgery centers, and others.

What Is The Radiotherapy Market Growth Forecast?

The radiotherapy market size is expected to see strong growth in the next few years. It will grow to $10.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing investments in proton therapy facilities, rising focus on personalized radiation dosing, expansion of outpatient radiotherapy centers, growing integration of ai-based planning systems, increasing demand for high-precision cancer therapies. Major trends in the forecast period include increasing adoption of advanced external beam techniques, growing use of image-guided and adaptive radiotherapy, rising demand for proton and particle therapy, expansion of multimodal cancer treatment approaches, enhanced focus on treatment planning accuracy.

Global Radiotherapy Market Segmentation

1) By Therapy Type: External Beam Radiation Therapy, Internal Beam Radiation Therapy, Systemic Radiation Therapy 2) By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, Gynecological Cancer, Cervical Cancer, Penile Cancer, Other Applications 3) By End-User: Hospitals And Diagnostic Laboratories, Cancer Treatment And Research Centers, Academic Research Organizations, Ambulatory Surgery Centers, Other End-Users Subsegments: 1) By External Beam Radiation Therapy: Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), 3D Conformal Radiation Therapy (3D-CRT), Proton Beam Therapy, Image-Guided Radiation Therapy (IGRT), Volumetric Modulated Arc Therapy (VMAT) 2) By Internal Beam Radiation Therapy: Brachytherapy (High-Dose Rate), Brachytherapy (Low-Dose Rate), Intraoperative Radiation Therapy (IORT), Permanent Seed Implants 3) By Systemic Radiation Therapy: Radioisotope Therapy, Targeted Radionuclide Therapy, Radioimmunotherapy, Peptide Receptor Radionuclide Therapy (PRRT)

What Is The Driver Of The Radiotherapy Market?

The increasing prevalence of cancer is expected to drive the growth of the radiotherapy market going forward. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body, arising in various tissues and organs and leading to diverse types and symptoms. The increasing prevalence of cancer can be attributed to factors such as an aging population, lifestyle changes including poor diet and sedentary behavior, high rates of tobacco and alcohol use, environmental pollution, and better diagnostic tools leading to more cases being detected. Radiotherapy plays a crucial role in cancer treatment by targeting and destroying cancerous cells with precision, helping to reduce tumor size and improve patient outcomes. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based charitable organization to support cancer patients, it was reported that, in 2024, more than 3 million people in the UK are living with cancer, this figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of the radiotherapy industry.

Key Players In The Global Radiotherapy Market

Major companies operating in the radiotherapy market are Hitachi Ltd., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.

Global Radiotherapy Market Trends and Insights

Major companies operating in the radiotherapy market are focusing on developing advanced solutions, such as image-guided radiotherapy (IGRT), to improve treatment precision, reduce healthy tissue exposure, and enhance patient outcomes. Image-guided radiotherapy (IGRT) refers to the use of advanced imaging systems, such as onboard CT or MRI, combined with adaptive software to monitor and adjust radiation delivery in real time based on tumor location and movement. For instance, in May 2024, Elekta AB, a Sweden-based medical technology company, launched Elekta Evo CT-Linac, its next-generation adaptive radiotherapy system featuring high-definition AI-enhanced imaging and online adaptive workflow. Designed to assist clinicians in delivering more precise and personalized radiation therapy, the system supports a wide range of treatment protocols while minimizing exposure to organs at risk.

What Are Latest Mergers And Acquisitions In The Radiotherapy Market?

In February 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired RayzeBio Inc. for an undisclosed amount. This acquisition enhances its oncology pipeline with cutting-edge radiopharmaceutical therapeutics, including the promising RYZ101, targeting SSTR2 in GEP-NETs and ES-SCLC. With ongoing clinical trials and a state-of-the-art manufacturing facility, this move positions BMS to accelerate innovation, diversify treatment options, and drive growth in the oncology sector. RayzeBio Inc. is a US-based company that specializes in developing innovative radiopharmaceuticals for cancer.

Regional Outlook

North America was the largest region in the radiotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiotherapy Market?

The radiotherapy market includes revenues earned by entities by providing services such as brachytherapy, palliative radiotherapy, proton therapy, and intraoperative radiotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiotherapy market consists of sales of patient positioning systems, surface-guided radiation therapy systems (SGRT), CT and MRI simulation systems, and linear accelerators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radiotherapy Market Report 2026?

The radiotherapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.